Reduction in blood glutathione levels occurs similarly in patients with primary-open angle or normal tension glaucoma

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 5, 2013, Pages 3333-3339

  Gherghel, Doina ^a   Mroczkowska, Stephanie ^a   Qin, Lu ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Glutathione; Normal tension glaucoma; Open angle glaucoma

Indexed keywords

GLUTATHIONE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GONIOSCOPY; HUMAN; LOW TENSION GLAUCOMA; MALE; OCULOPLETHYSMOGRAPHY; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; PSEUDOEXFOLIATION; VISUAL FIELD DEFECT;

GLUTATHIONE; NORMAL TENSION GLAUCOMA; OPEN ANGLE GLAUCOMA;

AGE DISTRIBUTION; ARTERIAL PRESSURE; BLOOD PRESSURE; DISEASE PROGRESSION; FASTING; FEMALE; GLAUCOMA, OPEN-ANGLE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GREAT BRITAIN; HUMANS; INTRAOCULAR PRESSURE; LOW TENSION GLAUCOMA; MALE; MIDDLE AGED; SEX DISTRIBUTION;

EID: 84877666417     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-11256     Document Type: Article

References (56)

1. Gherghel D, Hosking SL, Armstrong R, Cunliffe IA. Autonomic dysfunction in unselected and untreated primary open angle glaucoma patients: a pilot study. Ophthalmic Physiol Opt. 2007;27:336-341.
2. Gherghel D, Chiselita D. Open angle glaucoma identification of vascular risk factors. Oftalmologia. 2000;50:17-27.
3. Garhofer G, Zawinka C, Resch H, Huemer KH, Schmetterer L, Dorner GT. Response of retinal vessel diameters to flicker stimulation in patients with early open angle glaucoma. J Glaucoma. 2004;13:340-344.
4. Su WW, Cheng ST, Ho WJ, Tsay PK, Wu SC, Chang SH. Glaucoma is associated with peripheral vascular endothelial dysfunction. Ophthalmology. 2008;115:1173-1178.e1.
5. Pemp B, Georgopoulos M, Vass C, et al. Diurnal fluctuation of ocular blood flow parameters in patients with primary open-angle glaucoma and healthy subjects. Br J Ophthalmol. 2009; 93:486-491.
6. Feke GT, Pasquale LR. Retinal blood flow response to posture change in glaucoma patients compared with healthy subjects. Ophthalmology. 2008;115:246-252.
7. Mroczkowska S, Ekart A, Sung V, et al. Coexistence of macro-and micro-vascular abnormalities in newly diagnosed normal tension glaucoma patients. Acta Ophthalmol. 2012;80:e55-e559.
8. Oettli A, Gugleta K, Kochkorov A, Katamay R, Flammer J, Orgul S. Rigidity of retinal vessel in untreated eyes of normal tension primary open-angle glaucoma patients. J Glaucoma. 2011;20:303-306.
9. Su WW, Cheng ST, Hsu TS, Ho WJ. Abnormal flow-mediated vasodilation in normal-tension glaucoma using a noninvasive determination for peripheral endothelial dysfunction. Invest Ophthalmol Vis Sci. 2006;47:3390-3394.
10. Gasser P, Flammer J. Blood-cell velocity in the nailfold capillaries of patients with normal-tension and high-tension glaucoma. Am J Ophthalmol. 1991;111:585-588.
11. Mroczkowska S, Benavente-Perez A, Negi A, Sung V, Patel SR, Gherghel D. Primary open-angle glaucoma vs normal-tension glaucoma: the vascular perspective. JAMA Ophthalmol. 2013; 131:36-43.
12. Gherghel D, Hosking SL, Orgul S. Autonomic nervous system, circadian rhythms, and primary open-angle glaucoma. Surv Ophthalmol. 2004;49:491-508.
13. Cellini M, Strobbe E, Gizzi C, Balducci N, Toschi PG, Campos EC. Endothelin-1 plasma levels and vascular endothelial dysfunction in primary open angle glaucoma. Life Sci. 2012; 91:699-702.
14. Majsterek I, Malinowska K, Stanczyk M, et al. Evaluation of oxidative stress markers in pathogenesis of primary open-angle glaucoma. Exp Mol Pathol. 2011;90:231-237.
15. Gherghel D, Griffiths HR, Hilton EJ, Cunliffe IA, Hosking SL. Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2005;46:877-883.
16. Sacca SC, Izzotti A, Rossi P, Traverso C. Glaucomatous outflow pathway and oxidative stress. Exp Eye Res. 2007;84:389-399.
17. Mozaffarieh M, Grieshaber MC, Flammer J. Oxygen and blood flow: players in the pathogenesis of glaucoma. Mol Vis. 2008; 14:224-233.
18. Sies H. Total antioxidant capacity: appraisal of a concept. J Nutr. 2007;137:1493-1495.
19. Alp NJ, Channon KM. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler Thromb Vasc Biol. 2004;24:413-420.
20. Vallance P, Chan N. Endothelial function and nitric oxide: clinical relevance. Heart. 2001;85:342-350.
21. Pache M, Dubler B, Flammer J. Peripheral vasospasm and nocturnal blood pressure dipping-two distinct risk factors for glaucomatous damage? Eur J Ophthalmol. 2003;13:260-265.
22. Schmetterer L, Polak K. Role of nitric oxide in the control of ocular blood flow. Prog Retin Eye Res. 2001;20:823-847.
23. '-deoxy-guanosine levels in patients with normal-tension glaucoma. Acta Ophthalmol. 2010;88:e259-e264.
24. Ahsan H, Ali A, Ali R. Oxygen free radicals and systemic autoimmunity. Clin Exp Immunol. 2003;131:398-404.
25. Videla LA, Guerri C. Glutathione and alcohol. In: Vina J, ed. Glutathione: Metabolism and Physiological Functions. Boca Raton, FL: CRC Press; 1990:57-67.
26. Beutler E, Gelbart T. Plasma glutathione in health and in patients with malignant disease. J Lab Clin Med. 1985;105: 581-584.
27. Beard KM, Shangari N, Wu B, O'Brien PJ. Metabolism, not autoxidation, plays a role in alpha-oxoaldehyde-and reducing sugar-induced erythrocyte GSH depletion: relevance for diabetes mellitus. Mol Cell Biochem. 2003;252:331-338.
28. Anderson ME. Glutathione. In: Punchard NA, Kelly FJ, eds. Free Radicals: A Practical Approach. Oxford, UK: Oxford University; 1996:213-236.
29. Samiec PS, Drews-Botsch C, Flagg EW, et al. Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic Biol Med. 1998;24:699-704.
30. Anderson ME, Meister A. Dynamic state of glutathione in blood plasma. J Biol Chem. 1980;255:9530-9533.
31. Jones DP, Carlson JL, Samiec PS, et al. Glutathione measurement in human plasma. Evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC. Clin Chim Acta. 1998;275:175-184.
32. Qin L, Bartlett H, Griffiths HR, Eperjesi F, Armstrong RA, Gherghel D. Macular pigment optical density is related to blood glutathione levels in healthy individuals. Invest Ophthalmol Vis Sci. 2011;52:5029-5033.
33. Jones DP, Coates RJ, Flagg EW, et al. Glutathione in foods listed in the national cancer institute's health habits and history food frequency questionnaire. Nutr Cancer. 1992;17:57-75.
34. Pompella A, Visvikis A, Paolicchi A, De Tata V, Casini AF. The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol. 2003;66:1499-1503.
35. Matsubara LS, Machado PE. Age-related changes of glutathione content, glutathione reductase and glutathione peroxidase activity of human erythrocytes. Braz J Med Biol Res. 1991;24: 449-454.
36. Lang CA, Naryshkin S, Schneider DL, Mills BJ, Lindeman RD. Low blood glutathione levels in healthy aging adults. J Lab Clin Med. 1992;120:720-725.
37. Erden-Inal M, Sunal E, Kanbak G. Age-related changes in the glutathione redox system. Cell Biochem Funct. 2002;20:61-66.
38. Knight JA. The biochemistry of aging. Adv Clin Chem. 2000; 35:1-62.
39. Sekhar RV, Patel SG, Guthikonda AP, et al. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am J Clin Nutr. 2011;94:847-853.
40. Flagg EW, Coates RJ, Jones DP, et al. Plasma total glutathione in humans and its association with demographic and health-related factors. Br J Nutr. 1993;70:797-808.
41. Michelet F, Gueguen R, Leroy P, Wellman M, Nicolas A, Siest G. Blood and plasma glutathione measured in healthy subjects by HPLC: relation to sex, aging, biological variables, and life habits. Clin Chem. 1995;41:1509-1517.
42. Alvarado J, Murphy C, Juster R. Trabecular meshwork cellularity in primary open-angle glaucoma and nonglaucomatous normals. Ophthalmology. 1984;91:564-579.
43. Nguyen KP, Weiss H, Karageuzian LN, Anderson PJ, Epstein DL. Glutathione reductase of calf trabecular meshwork. Invest Ophthalmol Vis Sci. 1985;26:887-890.
44. Levin LA, Clark JA, Johns LK. Effect of lipid peroxidation inhibition on retinal ganglion cell death. Invest Ophthalmol Vis Sci. 1996;37:2744-2749.
45. Izzotti A, Sacca SC, Cartiglia C, De Flora S. Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients. Am J Med. 2003;114:638-646.
46. Ferreira SM, Lerner SF, Brunzini R, Evelson PA, Llesuy SF. Oxidative stress markers in aqueous humor of glaucoma patients. Am J Ophthalmol. 2004;137:62-69.
47. Ghanem AA, Arafa LF, El-Baz A. Oxidative stress markers in patients with primary open-angle glaucoma. Curr Eye Res. 2010;35:295-301.
48. Park MH, Moon J. Circulating total glutathione in normal tension glaucoma patients: comparison with normal control subjects. Korean J Ophthalmol. 2012;26:84-91.
49. Demailly P, Cambien F, Plouin PF, Baron P, Chevallier B. Do patients with low tension glaucoma have particular cardiovascular characteristics? Ophthalmologica. 1984;188:65-75.
50. Drance SM, Sweeney VP, Morgan RW, Feldman F. Studies of factors involved in the production of low tension glaucoma. Arch Ophthalmol. 1973;89:457-465.
51. Buckley C, Hadoke PW, Henry E, O'Brien C. Systemic vascular endothelial cell dysfunction in normal pressure glaucoma. Br J Ophthalmol. 2002;86:227-232.
52. Yang YM, Huang A, Kaley G, Sun D. eNOS uncoupling and endothelial dysfunction in aged vessels. Am J Physiol Heart Circ Physiol. 2009;297:H1829-H1836.
53. El Assar M, Angulo J, Vallejo S, Peiro C, Sanchez-Ferrer CF, Rodriguez-Manas L. Mechanisms involved in the aging-induced vascular dysfunction. Front Physiol. 2012;3:132.
54. Sorkhabi R, Ghorbanihaghjo A, Javadzadeh A, Rashtchizadeh N, Moharrery M. Oxidative DNA damage and total antioxidant status in glaucoma patients. Mol Vis. 2011;17:41-46.
55. Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem. 1980;106:207-212.
56. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007; 39:44-84.